Half-year report · Q2
1757.TEDINET S100WHKW
Period2024-04-01 → 2024-09-30
Filed2025-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amends S100USBZ. Amended by S100WHQR (2025-08-07).
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥992m | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥963m | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥223m | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | −¥207m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | −¥264m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | −¥222m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥595m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥283m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥433m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥279m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥434m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥591m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥282m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥434m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | −¥282m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥3.0bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥1.4bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥1.1bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.5bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.0bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥493m | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥324m | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥318m | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥30m | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥232m | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥30m | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥232m | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥19m | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥67m | at 2023-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥652m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥804m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥495m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥31m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥498m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥495m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥481m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥942m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-1.52 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.22 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.07 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 16.4% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.6% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.6% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 29
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥13m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥13m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | −¥12m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥179m |
| jpcrp040300-q2r_E00288-000Construction Workreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥845m |
| jpcrp040300-q2r_E00288-000Construction Workreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥845m |
| jpcrp040300-q2r_E00288-000Construction Workreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥22m |
| jpcrp040300-q2r_E00288-000House Produce Segmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥103m |
| jpcrp040300-q2r_E00288-000House Produce Segmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥103m |
| jpcrp040300-q2r_E00288-000House Produce Segmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥4m |
| jpcrp040300-q2r_E00288-000Medical Segmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥30m |
| jpcrp040300-q2r_E00288-000Medical Segmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥30m |
| jpcrp040300-q2r_E00288-000Medical Segmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥3m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥979m |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥979m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | −¥15m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥35m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥35m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥15m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥231m |
| jpcrp040300-q2r_E00288-000Construction Workreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥180m |
| jpcrp040300-q2r_E00288-000Construction Workreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥180m |
| jpcrp040300-q2r_E00288-000Construction Workreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥43m |
| jpcrp040300-q2r_E00288-000Cosmetic Hygiene Related Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥8m |
| jpcrp040300-q2r_E00288-000Cosmetic Hygiene Related Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥8m |
| jpcrp040300-q2r_E00288-000Cosmetic Hygiene Related Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥5m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥188m |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥188m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | −¥48m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 563
| Item | Context | Value | Unit |
|---|---|---|---|
| Liabilities | CurrentQuarterInstant | 2458453000 | JPY |
| Capital stock | Prior1YearInstant | 10966980000 | JPY |
| Capital stock | CurrentQuarterInstant | 10966980000 | JPY |
| Capital surplus | Prior1YearInstant | 4205586000 | JPY |
| Capital surplus | CurrentQuarterInstant | 4814586000 | JPY |
| Retained earnings | Prior1YearInstant | -14859252000 | JPY |
| Retained earnings | CurrentQuarterInstant | -15293001000 | JPY |
| Treasury stock | Prior1YearInstant | -5948000 | JPY |
| Treasury stock | CurrentQuarterInstant | -5954000 | JPY |
| Shareholders equity | Prior1YearInstant | 307365000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 482610000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 16650000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 9925000 | JPY |
| Net assets | Prior1YearInstant | 324015000 | JPY |
| Net assets | CurrentQuarterInstant | 492535000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 1362051000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 2950988000 | JPY |
| Net sales | Prior1YTDDuration | 223189000 | JPY |
| Net sales | CurrentYTDDuration | 991526000 | JPY |
| Cost of sales | Prior1YTDDuration | 191726000 | JPY |
| Cost of sales | CurrentYTDDuration | 855298000 | JPY |
| Gross profit | Prior1YTDDuration | 31462000 | JPY |
| Gross profit | CurrentYTDDuration | 136228000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 295005000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 342976000 | JPY |
| Operating income | Prior1YTDDuration | -263542000 | JPY |
| Operating income | CurrentYTDDuration | -206748000 | JPY |
| Interest income noi | Prior1YTDDuration | 0 | JPY |
| Interest income noi | CurrentYTDDuration | 11000 | JPY |
| Reversal of allowance for doubtful accounts noi | Prior1YTDDuration | 5759000 | JPY |
| Reversal of allowance for doubtful accounts noi | CurrentYTDDuration | - | JPY |
| Other noi | Prior1YTDDuration | 716000 | JPY |
| Other noi | CurrentYTDDuration | 3907000 | JPY |
| Non operating income | Prior1YTDDuration | 6477000 | JPY |
| Non operating income | CurrentYTDDuration | 3919000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 109000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 8820000 | JPY |
| Stock issuance cost noe | Prior1YTDDuration | 8115000 | JPY |
| Stock issuance cost noe | CurrentYTDDuration | 6594000 | JPY |
| Loss on disposal of noncurrent assets noe | Prior1YTDDuration | 14618000 | JPY |
| Loss on disposal of noncurrent assets noe | CurrentYTDDuration | - | JPY |
| Amortization of deferred organization expenses noe | Prior1YTDDuration | - | JPY |
| Amortization of deferred organization expenses noe | CurrentYTDDuration | 205000 | JPY |
| Other noe | Prior1YTDDuration | 2642000 | JPY |
| Other noe | CurrentYTDDuration | 3158000 | JPY |
| Non operating expenses | Prior1YTDDuration | 25485000 | JPY |
| Non operating expenses | CurrentYTDDuration | 18777000 | JPY |
| Ordinary income | Prior1YTDDuration | -282551000 | JPY |
| Ordinary income | CurrentYTDDuration | -221606000 | JPY |
| Gain on sales of subsidiaries stocks ei | Prior1YTDDuration | 3557000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |